IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 90 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1The Potential Use of the CRISPR-Cas System for HIV-1 Gene Therapy
Gabriela De Nardi Sanches-da-Silva,Luiza Fonseca Sales Medeiros,Fabio Mitsuo Lima
International Journal of Genomics.2019;2019()1
[DOI]
2Investigating Organ Toxicity Profile of Tenofovir and Tenofovir Nanoparticle on the Liver and Kidney: Experimental Animal Study
Aniekan Imo Peter,Edwin CS Naidu,Edidiong Akang,Oluwatosin O Ogedengbe,Ugochukwu Offor,Sanjeev Rambharose,Rahul Kalhapure,Anil Chuturgoon,Thirumala Govender,Onyemaechi O Azu
Toxicological Research.2018;34(3)221
[DOI]
3Gold(I) complex of 1,1'-bis(diphenylphosphino) ferrocene–quinoline conjugate: a virostatic agent against HIV-1
Ntombenhle Gama,Kamlesh Kumar,Erik Ekengard,Matti Haukka,James Darkwa,Ebbe Nordlander,Debra Meyer
BioMetals.2016;29(3)389
[DOI]
4Gold(I) complex of 1,1'-bis(diphenylphosphino) ferrocene–quinoline conjugate: a virostatic agent against HIV-1
Santosh Kumar Singh,Sunit K. Singh
BioMetals.2018;29(3)61
[DOI]
5Development and in Vitro Evaluation of a Microbicide Gel Formulation for a Novel Non-Nucleoside Reverse Transcriptase Inhibitor Belonging to the N-Dihydroalkyloxybenzyloxopyrimidines (N-DABOs) Family
Cristina Tintori,Annalaura Brai,Maria Chiara Dasso Lang,Davide Deodato,Antonia Michela Greco,Bruno Mattia Bizzarri,Lorena Cascone,Alexandru Casian,Claudio Zamperini,Elena Dreassi,Emmanuele Crespan,Giovanni Maga,Guido Vanham,Elisa Ceresola,Filippo Canducci,Kevin K. Ariën,Maurizio Botta
Journal of Medicinal Chemistry.2016;59(6)2747
[DOI]
6HIV infection and its effects on the development of autoimmune disorders
Luis E. Vega,Luis R. Espinoza
Pharmacological Research.2018;129(6)1
[DOI]
7The landscape of alternative splicing in HIV-1 infected CD4 T-cells
Seyoun Byun,Seonggyun Han,Yue Zheng,Vicente Planelles,Younghee Lee
BMC Medical Genomics.2020;13(S5)1
[DOI]
8Recent advance of the hepatitis B virus inhibitors: a medicinal chemistry overview
Haiyong Jia,Diwakar Rai,Peng Zhan,Xuwang Chen,Xuemei Jiang,Xinyong Liu
Future Medicinal Chemistry.2015;7(5)587
[DOI]
9Recent advance of the hepatitis B virus inhibitors: a medicinal chemistry overview
María José Abad Martínez,Luis Miguel Bedoya del Olmo,Paulina Bermejo Benito
Future Medicinal Chemistry.2014;43(5)197
[DOI]
10Development of peptide inhibitors of HIV transmission
Siyu Shi,Peter K. Nguyen,Henry J. Cabral,Ramon Diez-Barroso,Paul J. Derry,Satoko M. Kanahara,Vivek A. Kumar
Bioactive Materials.2016;1(2)109
[DOI]
11HIV Capsid and Protease, New Targets of Melittin
Behzad Dehghani,Zahra Hasanshahi,Tayebeh Hashempour
International Journal of Peptide Research and Therapeutics.2020;1(2)109
[DOI]
12An Overview of Antiretroviral Agents for Treating HIV Infection in Paediatric Population
Rita Melo,Agostinho Lemos,António J. Preto,Beatriz Bueschbell,Pedro Matos-Filipe,Carlos Barreto,José G. Almeida,Rúben D.M. Silva,João D.G. Correia,Irina S. Moreira
Current Medicinal Chemistry.2020;27(5)760
[DOI]
13Lessons Learned From Failures and Success Stories of HIV Breakthroughs: Are We Getting Closer to an HIV Cure?
V. Kalidasan,Kumitaa Theva Das
Frontiers in Microbiology.2020;11(5)760
[DOI]
14Lessons Learned From Failures and Success Stories of HIV Breakthroughs: Are We Getting Closer to an HIV Cure?
Anneleen Steels,Laurence Bertier,Jan Gettemans
Frontiers in Microbiology.2018;11(5)760
[DOI]
15Emerging need to use phytopharmaceuticals in the treatment of HIV
L. Chaitra Narayan,V. Ravishankar Rai,Supinya Tewtrakul
Journal of Pharmacy Research.2013;6(1)218
[DOI]
16Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Biologically Active Agents
Maria Assunta Chiacchio,Daniela Iannazzo,Roberto Romeo,Salvatore V. Giofrè,Laura Legnani
Current Medicinal Chemistry.2020;26(40)7166
[DOI]
17Sphingolipids as Potential Therapeutic Targets against Enveloped Human RNA Viruses
Laura Yager,Laura Konan
Viruses.2019;11(10)912
[DOI]
18Determinants of virological failure among adults on first-line highly active antiretroviral therapy at public health facilities in Kombolcha town, Northeast, Ethiopia: a case–control study
Habtamu Mengist Meshesha,Zelalem Mehari Nigussie,Anemaw Asrat,Kebadnew Mulatu
BMJ Open.2020;10(7)e036223
[DOI]
19Current Computational Approaches for the Development of Anti-HIV Inhibitors: An Overview
Umesh Panwar,Ishwar Chandra,Chandrabose Selvaraj,Sanjeev K. Singh
Current Pharmaceutical Design.2019;25(31)3390
[DOI]
20Evaluation of PD 404,182 as an Anti-HIV and Anti-Herpes Simplex Virus Microbicide
Ana M. Chamoun-Emanuelli,Michael Bobardt,Bernard Moncla,Marie K. Mankowski,Roger G. Ptak,Philippe Gallay,Zhilei Chen
Antimicrobial Agents and Chemotherapy.2014;58(2)687
[DOI]
21Evaluation of PD 404,182 as an Anti-HIV and Anti-Herpes Simplex Virus Microbicide
Naveed Shahzad,Roman Farooq,Bilal Aslam,Muhammad Umer
Antimicrobial Agents and Chemotherapy.2017;58(2)687
[DOI]
22Laser-enhanced drug delivery of antiretroviral drugs into human immunodeficiency virus-1 infected TZMbl cells
Rudzani Malabi,Sello Lebohang Manoto,Saturnin Ombinda-Lemboumba,Malik Maaza,Patience Mthunzi-Kufa
Journal of Biophotonics.2019;12(10)687
[DOI]
23Approaches for CNS delivery of drugs – nose to brain targeting of antiretroviral agents as a potential attempt for complete elimination of major reservoir site of HIV to aid AIDS treatment
Shweta Gupta,Rajesh Kesarla,Abdelwahab Omri
Expert Opinion on Drug Delivery.2019;16(3)287
[DOI]
24Polymeric therapeutic delivery systems for the treatment of infectious diseases
Blessing A Aderibigbe
Therapeutic Delivery.2017;8(7)557
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow